Boehringer Ingelheim Animal Health USA Inc. has voluntarily recalled 16,165 bottles of Vetmedin (pimobendan) Chewable Tablets, 1.25 mg, which are used to treat certain types of heart disease in dogs. This recall was initiated due to deviations from Current Good Manufacturing Practice (cGMP) standards during the production process. While no specific animal illnesses have been reported in this notice, products not manufactured according to strict quality standards may not meet safety or effectiveness requirements. Consumers who have purchased these bottles should verify if their medication belongs to the affected batch from October 2020.
The recall is due to manufacturing deviations (cGMP), which means the medication may not meet quality specifications for potency or stability, potentially affecting the treatment's efficacy for a dog's heart condition.
Drug Recall Refund/Guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response